3. Drug such as methotrexate which inhibit DNA synthesis are generally used for treatment of cancer because-
   (1) Cancer cells are converted into normal cells
   (2) Drugs act on all rapidly dividing cells
   (3) Only cancerous cells are selectively eliminated
   (4) Enzyme telomerase is inhibited

SEO Content: Why Methotrexate and Other DNA Synthesis Inhibitors Are Used in Cancer Treatment

Methotrexate is one of the cornerstone drugs used in cancer chemotherapy. It is an antimetabolite that works by inhibiting DNA synthesis, a process essential for cell division and growth. This mechanism makes methotrexate and other DNA synthesis inhibitors effective against cancer cells, which divide rapidly.

Understanding Methotrexate and DNA Synthesis Inhibition

Methotrexate belongs to a class of drugs called antimetabolites. It interferes with the growth of cancer cells by blocking the enzyme dihydrofolate reductase (DHFR). This enzyme is crucial for producing tetrahydrofolate, a molecule needed to synthesize DNA building blocks (nucleotides).

Without the ability to produce DNA, cells cannot replicate their genetic material or divide properly. This leads to cell death, particularly in cells that are actively dividing.

Why Target DNA Synthesis in Cancer?

Cancer is characterized by uncontrolled cell division. Cancer cells proliferate much faster than normal cells, continuously making copies of their DNA to produce new cells.

By targeting DNA synthesis, methotrexate disrupts this unchecked growth. Since cancer cells depend heavily on rapid DNA replication, they are more vulnerable to drugs that disrupt this process.

Why Methotrexate Acts on Rapidly Dividing Cells (Correct Answer: Option 2)

Methotrexate and similar drugs generally affect all rapidly dividing cells, not just cancerous ones. This includes:

• Cancer cells

• Cells in hair follicles

• Bone marrow cells producing blood cells

• Cells lining the gastrointestinal tract

This characteristic explains why chemotherapy often causes side effects such as hair loss, low white blood cell count, and gastrointestinal upset.

Debunking Other Options

• Methotrexate does not convert cancer cells into normal cells. Instead, it kills cells by preventing replication.

• It is not selective only for cancer cells; normal rapidly dividing cells are also affected.

• Methotrexate does not primarily work by inhibiting the enzyme telomerase, which is involved in chromosome protection in some cancer cells. Its main action is DHFR inhibition leading to DNA synthesis blockade.

Clinical Uses of Methotrexate in Cancer Therapy

Methotrexate is used to treat various cancers, including:

• Leukemias

• Lymphomas

• Breast cancer

• Osteosarcoma

• Certain types of lung and head-and-neck cancers

It can be administered alone or in combination with other drugs to improve efficacy. Dosage and regimen depend on the cancer type and patient condition.

Side Effects and Management

Because methotrexate affects all rapidly dividing cells, common side effects include:

• Bone marrow suppression causing anemia and infection risk

• Mouth sores and gastrointestinal toxicity

• Hair loss

• Liver and kidney toxicity at high doses

Regular monitoring and supportive care help manage these effects.

Advances in DNA Synthesis Inhibitors and Cancer Therapy

Research continues to develop newer agents with greater selectivity for cancer cells, aiming to reduce side effects and improve outcomes. Some approaches combine DNA synthesis inhibitors with targeted therapies to maximize tumor destruction while sparing normal tissues.

Conclusion

Drugs like methotrexate are fundamental in cancer treatment because they inhibit DNA synthesis, stopping rapidly dividing cancer cells from proliferating. While not selective exclusively for cancer cells, their ability to target all fast-growing cells makes them effective cytotoxic agents in chemotherapy.

Understanding this mechanism provides insights into why methotrexate causes certain side effects and how it fits into the broader cancer treatment landscape.